🇺🇸 FDA
Patent

US 10314889

Suppression of allergic lung inflammation and hyperreactivity

granted A61KA61K38/10A61K38/1709

Quick answer

US patent 10314889 (Suppression of allergic lung inflammation and hyperreactivity) held by The Regents of the University of California expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K38/10, A61K38/1709, A61K38/177, A61K9/007